These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 22500781

  • 1. A review of augmentation therapy for alpha-1 antitrypsin deficiency.
    Mohanka M, Khemasuwan D, Stoller JK.
    Expert Opin Biol Ther; 2012 Jun; 12(6):685-700. PubMed ID: 22500781
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.
    Chorostowska-Wynimko J, Barrecheguren M, Ferrarotti I, Greulich T, Sandhaus RA, Campos M.
    Int J Chron Obstruct Pulmon Dis; 2020 Jun; 15():345-355. PubMed ID: 32103933
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Expert statement for augmentation therapy in patients with alpha-1 antitrypsin deficiency].
    Köhnlein T, Schmidt-Scherzer K, Greulich T, Bals R.
    Pneumologie; 2014 Jul; 68(7):492-5. PubMed ID: 25006842
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
    Campos MA, Lascano J.
    Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
    [Abstract] [Full Text] [Related]

  • 16. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.
    O'Brien ME, Fee L, Browne N, Carroll TP, Meleady P, Henry M, McQuillan K, Murphy MP, Logan M, McCarthy C, McElvaney OJ, Reeves EP, McElvaney NG.
    Thorax; 2020 Apr; 75(4):321-330. PubMed ID: 31959730
    [Abstract] [Full Text] [Related]

  • 17. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Heresi GA, Stoller JK.
    Expert Opin Biol Ther; 2008 Apr; 8(4):515-26. PubMed ID: 18352854
    [Abstract] [Full Text] [Related]

  • 18. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
    McCarthy C, Reeves EP, McElvaney NG.
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
    [Abstract] [Full Text] [Related]

  • 19. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals.
    Hurley K, Lacey N, O'Dwyer CA, Bergin DA, McElvaney OJ, O'Brien ME, McElvaney OF, Reeves EP, McElvaney NG.
    J Immunol; 2014 Oct 15; 193(8):3978-91. PubMed ID: 25217166
    [Abstract] [Full Text] [Related]

  • 20. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
    O'Dwyer CA, O'Brien ME, Wormald MR, White MM, Banville N, Hurley K, McCarthy C, McElvaney NG, Reeves EP.
    J Immunol; 2015 Oct 15; 195(8):3628-41. PubMed ID: 26371243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.